FFAR2 and Other metabolic disease: The mechanism affecting these metabolic diseases was the short-chain fatty acids (SCFAs) produced by Akkermansia bind to GPR43 and PR41, thereby stimulating GLP1 and GLP2 secretion and mucus production and secretion, consequently regulating the glucose metabolism and intestinal function (Cani et al., 2022).